title: Role of endogenous GLP-1 and GIP in beta cell compensatory responses to insulin resistance and cellular stress.
abstract: Role of GLP-1 and GIP in beta cell compensatory responses to beta cell attack and insulin resistance were examined in C57BL/6 mice lacking functional receptors for GLP-1 and GIP. Mice were treated with multiple low dose streptozotocin or hydrocortisone. Islet parameters were assessed by immunohistochemistry and hormone measurements were determined by specific enzyme linked immunoassays. Wild-type streptozotocin controls exhibited severe diabetes, irregularly shaped islets with lymphocytic infiltration, decreased Ki67/TUNEL ratio with decreased beta cell and increased alpha cell areas. GLP-1 and GIP were co-expressed with glucagon and numbers of alpha cells mainly expressing GLP-1 were increased. In contrast, hydrocortisone treatment and induction of insulin resistance increased islet numbers and area, with enhanced beta cell replication, elevated mass of beta and alpha cells, together with co-expression of GLP-1 and GIP with glucagon in islets. The metabolic responses to streptozotocin in GLP-1RKO and GIPRKO mice were broadly similar to C57BL/6 controls, although decreases in islet numbers and size were more severe. In contrast, both groups of mice lacking functional incretin receptors displayed substantially impaired islet adaptations to insulin resistance induced by hydrocortisone, including marked curtailment of expansion of islet area, beta cell mass and islet number. Our observations cannot be explained by simple changes in circulating incretin concentrations, suggesting that intra-islet GLP-1 and GIP make a significant contribution to islet adaptation, particularly expansion of beta cell mass and compensatory islet compensation to hydrocortisone and insulin resistance.
authors: SAAD Centre for Pharmacy and Diabetes, University of Ulster, Coleraine, Northern Ireland.
authors: Srividya
authors: S
authors: Vasu
authors: SAAD Centre for Pharmacy and Diabetes, University of Ulster, Coleraine, Northern Ireland.
authors: R Charlotte
authors: RC
authors: Moffett
authors: Centre for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.
authors: Bernard
authors: B
authors: Thorens
authors: SAAD Centre for Pharmacy and Diabetes, University of Ulster, Coleraine, Northern Ireland.
authors: Peter R
authors: PR
authors: Flatt
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D005749:Gastric Inhibitory Polypeptide / Q000378:metabolism*; D005934:Glucagon / Q000378:metabolism; D052216:Glucagon-Like Peptide 1 / Q000378:metabolism*; D006728:Hormones / Q000097:blood; D006854:Hydrocortisone / Q000494:pharmacology; D007333:Insulin Resistance; D050417:Insulin-Secreting Cells / Q000187:drug effects / Q000378:metabolism*; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008214:Lymphocytes / Q000473:pathology; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism; D021381:Protein Transport; D013311:Streptozocin / Q000494:pharmacology
chemical_list: D006728:Hormones; D005749:Gastric Inhibitory Polypeptide; D013311:Streptozocin; D052216:Glucagon-Like Peptide 1; D005934:Glucagon; D006854:Hydrocortisone